FY23 Full-Year Results Presentation

Regis Healthcare Limited | FY23 Full-Year Results Presentation FY23 Overview Financial Overview Revenue from services of $780.6 million, up 7.6% on pcp Underlying EBITDA1 of $83.3 million, up 6.7% on pcp NPATA¹ of $28.5 million, up 631% on pcp Statutory net loss after tax of $28.5 million impacted by non-cash bed licence amortisation² Net operating cash flow of $105.2 million includes net RAD receipts of $43.6 million Net debt of $6.0 million, down 94.2% or $96.9 million on pcp Board of Directors resolved to pay a final dividend of 7.48 cents per ordinary share (50% franked) payable 27 September 2023 Total dividends pay-out represents 100% of NPATA Operational Highlights Average occupancy of 91.5% (H2 FY23: 92.0%) significantly up on 89.8% in prior year Achieved all-time high of 6,521 occupied beds or 93.7% in June 2023 Improvement in average portfolio overall star rating from 3.11 (Q1 FY23) to 3.14 (Q3 FY23) Average care minutes increased from 165.3 minutes (Q1 FY23) to 178.8 minutes (Q4 FY23)³ Received net proceeds of $60 million from sale of non-income producing assets Revenue from Services Average Occupancy $780.6 million 91.5% Underlying EBITDA¹ Overall star rating (Q3 FY23) $83.3 million 3.14 NPATA¹ $28.5million Net Operating Cash Flow $105.2 million Net RAD Receipts $43.6 million Care minutes (Q4 FY23)³ 178.8 Net Debt $6.0 million Final Dividend 7.48 cents ¹Refer page 29 for definitions of Non-IFRS financial measures and page 27 for reconciliation of statutory results to Non-IFRS financial measures 2Net loss after tax includes $57.0m bed licence amortisation (after tax) during the year - refer page 29 3As submitted to DHAC -4 August 2023 - 7- regis healthcare

View entire presentation